AAVXF
Price
$7.28
Change
+$1.47 (+25.30%)
Updated
Jun 11 closing price
Capitalization
447.04M
MLEC
Price
$7.10
Change
-$0.58 (-7.55%)
Updated
Jun 27 closing price
Capitalization
28.4M
121 days until earnings call
Interact to see
Advertisement

AAVXF vs MLEC

Header iconAAVXF vs MLEC Comparison
Open Charts AAVXF vs MLECBanner chart's image
Abivax SA
Price$7.28
Change+$1.47 (+25.30%)
Volume$300
Capitalization447.04M
Moolec Science SA
Price$7.10
Change-$0.58 (-7.55%)
Volume$68.15K
Capitalization28.4M
AAVXF vs MLEC Comparison Chart in %
Loading...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. MLEC commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Buy and MLEC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (AAVXF: $7.28 vs. MLEC: $7.10)
Brand notoriety: AAVXF and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 197% vs. MLEC: 975%
Market capitalization -- AAVXF: $447.04M vs. MLEC: $28.4M
AAVXF [@Biotechnology] is valued at $447.04M. MLEC’s [@Biotechnology] market capitalization is $28.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileMLEC’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • MLEC’s FA Score: 0 green, 5 red.
According to our system of comparison, MLEC is a better buy in the long-term than AAVXF.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while MLEC (@Biotechnology) price change was +4.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

MLEC is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($447M) has a higher market cap than MLEC($28.4M). MLEC YTD gains are higher at: -11.250 vs. AAVXF (-34.118). MLEC has higher annual earnings (EBITDA): -5.24M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. MLEC (926K). MLEC has less debt than AAVXF: MLEC (22.1M) vs AAVXF (92.6M). MLEC has higher revenues than AAVXF: MLEC (7.83M) vs AAVXF (0).
AAVXFMLECAAVXF / MLEC
Capitalization447M28.4M1,574%
EBITDA-170.04M-5.24M3,243%
Gain YTD-34.118-11.250303%
P/E RatioN/AN/A-
Revenue07.83M-
Total Cash104M926K11,231%
Total Debt92.6M22.1M419%
FUNDAMENTALS RATINGS
AAVXF: Fundamental Ratings
AAVXF
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLEC
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
N/A
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend about 1 month ago
67%
TrendMonth
ODDS (%)
Bullish Trend about 1 month ago
25%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
N/A
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMI325.721.52
+0.47%
Cummins
DNB9.08N/A
N/A
Dun & Bradstreet Holdings
CIM14.06-0.03
-0.21%
Chimera Investment Corp
AFCG4.76-0.05
-1.14%
Advanced Flower Capital Inc
MSAI0.57-0.04
-6.66%
MultiSensor AI Holdings

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with WINT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
-7.49%
WINT - MLEC
49%
Loosely correlated
+21.49%
CTMX - MLEC
42%
Loosely correlated
-2.16%
AAVXF - MLEC
38%
Loosely correlated
N/A
ABEO - MLEC
36%
Loosely correlated
-2.54%
ABVC - MLEC
31%
Poorly correlated
+18.04%
More